JB Chemicals & Pharmaceuticals records Revenue growth of 19% to Rs. 528 crores for Q4 FY2021

JB Chemicals & Pharmaceuticals records Revenue growth of 19% to Rs. 528 crores for Q4 FY2021. J. B. Chemicals & Pharmaceuticals Limited (JBCPL), Quarterly Financial Performance – Q4 FY21 vs Q4 FY20 For fourth quarter ended 31st March 2021, the Company recorded revenue of Rs. 528 crores as compared to Rs 444 crores, registering growth of 19 % over corresponding quarter ended 31st March, 2020. EBITDA (Earnings Before Interest Depreciation and Taxes) increased by 35% to Rs. 124 crores as compared to … Read More

Roche Receives Approval for Laboratory Based Elecsys SARS-CoV-2 Antigen Test to Facilitate High-Volume Testing in the Country

Roche Receives Approval for Laboratory Based Elecsys SARS-CoV-2 Antigen Test to Facilitate High-Volume Testing in the Country. Roche announced today that it has launched a high-throughput SARS-CoV-2 antigen test as … Read More

J. B. Chemicals & Pharmaceuticals launches 360o Tobacco Cessation care on World No Tobacco Day: NOSMOK® nicotine lozenges

J. B. Chemicals & Pharmaceuticals Ltd., (BSE: 506943, NSE: JBCHEPHARM), one of the fastest growing pharmaceutical companies in India today announced the launch of NOSMOK® prescription medicated nicotine lozenges as part of a … Read More